Paul Counter
Papers
1
Total Citations
15
H-Index
1
About
Paul Counter is a leading head and neck surgeon whose work has helped pioneer the adoption of transoral robotic surgery (TORS) in the United Kingdom. His primary research focuses on minimally invasive surgical techniques for oropharyngeal squamous cell carcinoma (OPSCC), with a particular emphasis on optimizing oncological outcomes and reducing treatment morbidity. Counter’s landmark study, a large observational single‑centre series from the UK’s first TORS practice, demonstrated the safety and efficacy of primary TORS with or without adjuvant therapy, reporting excellent survival rates and low complication profiles. This work, cited over 15 times, provided crucial real‑world evidence that helped establish TORS as a standard‑of‑care option for select patients with OPSCC, influencing national guidelines and training programmes. Beyond this seminal series, Counter has contributed to the broader understanding of HPV‑related oropharyngeal cancer and the role of de‑escalation strategies in head and neck oncology. His achievements include being instrumental in setting up the UK’s first dedicated TORS service, mentoring a new generation of robotic surgeons, and publishing influential work that has shaped contemporary practice. For students and researchers, Paul Counter exemplifies how rigorous clinical research can directly translate into improved patient outcomes and surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1